Table 2.
A summary of representative genetic approaches used for evaluating the roles of EC-secreted factors in metabolic homeostasis.
| Secreted Factor | Model System | Signaling Effect and Metabolic Phenotype | Ref. |
|---|---|---|---|
| NO | |||
| e/n/iNOS−/− mice | Visceral obesity, hypertriglyceridemia, glucose intolerance | Nakata et al.(2008)123 | |
| ECM proteins | |||
| NOD mice | Degradation of islet basement membrane at onset of insulitis and diabetes | Irving-Rodgers et al.(2008)125 | |
| TSP-1 | TSP-1−/− mice, islet transplant-ation from WT/TSP-1−/− mice | Decreased insulin secretion and glucose tolerance, TSP-1 derived from ECs is important for insulin secretion | Olerud et al.(2011)126 |
| HGF | CCl4-induced mouse liver injury model, injected with VEGF agonist (Flt/KDR selective) | VEGF/Flt1 induces HGF and reduces liver damage | LeCouter et al.(2003)127 |
| PDGF-CC | Vegfr2iEC−/− and Pdgf-c−/−mice, Adenoviral PDGF-C | Impaired WAT-beige transition, adenoviral PDGF-C improves glucose tolerance in HFD-obese mice. | Seki et al.(2016)128 |
| EL | |||
| EL gene variants | Strong association with HDL level | Ma et al.(2003)130, Edmondson et al. (2009)132, Singaraja et al. (2013)133 |
iEC, inducible EC; epi, epithelial; NOD, non-obese diabetic; FAO, fatty acid oxidation